{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:35:16Z","timestamp":1764102916091},"reference-count":175,"publisher":"Elsevier","isbn-type":[{"value":"9780128136270","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/b978-0-12-813627-0.00008-9","type":"book-chapter","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T19:38:38Z","timestamp":1520451518000},"page":"293-329","source":"Crossref","is-referenced-by-count":5,"title":["Polymeric micelles as a versatile tool in oral chemotherapy"],"prefix":"10.1016","author":[{"given":"Andreza M.","family":"Ribeiro","sequence":"first","affiliation":[]},{"given":"Cl\u00e1udia","family":"Amaral","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Figueiras","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib1","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.2217\/nnm.15.58","article-title":"Carbohydrate-based materials for targeted delivery of drugs and genes to the liver","volume":"10","author":"Ahmed","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00280-014-2498-5","article-title":"A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer","volume":"74","author":"Ahn","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biomaterials.2014.10.069","article-title":"Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer","volume":"39","author":"Ahn","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib4","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2146\/ajhp070035","article-title":"Overview of the changing paradigm in cancer treatment: oral chemotherapy","volume":"64","author":"Aisner","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2005.08.003","article-title":"Preparation and characterization of biodegradable nanoparticles based on poly(\u03b3-glutamic acid) with l-phenylalanine as a protein carrier","volume":"108","author":"Akagi","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib6","doi-asserted-by":"crossref","first-page":"e72238","DOI":"10.1371\/journal.pone.0072238","article-title":"Effect of doxorubicin\/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia","volume":"8","author":"Alakhova","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2217\/nnm.10.53","article-title":"Inhibition of P-glycoprotein pumps by PEO\u2013PPO amphiphiles: branched versus linear derivatives","volume":"5","author":"Alvarez-Lorenzo","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2741\/e102","article-title":"Poloxamine-based nanomaterials for drug delivery","volume":"2","author":"Alvarez-Lorenzo","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.progpolymsci.2016.09.008","article-title":"Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy","volume":"64","author":"Amjad","year":"2017","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib10","unstructured":"Aurian-Blajeni, E., 2016. Poly(ethylene glycol)-based Biomaterials in Tissue Engineering. OpenWetWare."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/apmc.1984.051230121","article-title":"Watersoluble polymers in medicine","volume":"123","author":"Bader","year":"1984","journal-title":"Die Angew. Makromol. Chem."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib12","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1016\/j.biortech.2011.02.047","article-title":"Poly(glutamic acid)\u2014an emerging biopolymer of commercial interest","volume":"102","author":"Bajaj","year":"2011","journal-title":"Bioresour. Technol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/483531a","article-title":"Drug development: raise standards for preclinical cancer research","volume":"483","author":"Begley","year":"2012","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib14","first-page":"201","article-title":"Personalized medicine: theranostics (therapeutics diagnostics) essential for rational use of tumor necrosis factor-alpha antagonists","volume":"15","author":"Bendtzen","year":"2013","journal-title":"Discov. Med."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib15","first-page":"52","article-title":"Nanotechnology systems for oral drug delivery: challenges and opportunities","volume":"8","author":"Berardi","year":"2016","journal-title":"Nanotechnol. Drug Deliv."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0971-5851.68844","article-title":"Oral systemic therapy: not all \u201cwin-win\u201d","volume":"31","author":"Bhattacharyya","year":"2010","journal-title":"Ind. J. Med. Paediatr. Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.carbpol.2008.11.008","article-title":"Self-assembled micelles of N-phthaloylchitosan-g-polyvinylpyrrolidone for drug delivery","volume":"76","author":"Bian","year":"2009","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2012.09.033","article-title":"Nanoparticle and targeted systems for cancer therapy","volume":"64","author":"Brannon-Peppas","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.23144","article-title":"Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial","volume":"58","author":"Braun","year":"2008","journal-title":"Arth. Rheumat."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2008.01.018","article-title":"Polymeric micelles in oral chemotherapy","volume":"128","author":"Bromberg","year":"2008","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/B978-0-12-813627-0.00008-9_bib22","first-page":"2350","article-title":"Capecitabine and lapatinib treatment in head and neck cancer","volume":"122","author":"Brower","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/clpt.2012.73","article-title":"Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the achilles heel of targeted therapy?","volume":"92","author":"Budha","year":"2012","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00280-016-2986-x","article-title":"A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle","volume":"77","author":"Burris","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2014.06.042","article-title":"Progress of drug-loaded polymeric micelles into clinical studies","volume":"190","author":"Cabral","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib26","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.biotechadv.2013.08.010","article-title":"Polymeric nanoparticles for optical sensing","volume":"31","author":"Canfarotta","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib27","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1166\/jnn.2016.11323","article-title":"Iron oxide@ polypyrrole core\u2013shell nanoparticles as the platform for photothermal agent and electrochemical biosensor","volume":"16","author":"Cha","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib28","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/1097-0142(19841201)54:2+<2599::AID-CNCR2820541403>3.0.CO;2-M","article-title":"Cancer chemotherapy: progress and expectations, 1984","volume":"54","author":"Chabner","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib29","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/IJN.S45429","article-title":"Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics","volume":"8","author":"Chen","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib30","first-page":"73","article-title":"Pluronic P105\/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation","volume":"8","author":"Chen","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib31","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1039\/C4TB01962H","article-title":"Biodegradable glycopolymer-b-poly (\u03b5-caprolactone) block copolymer micelles: versatile construction, tailored lactose functionality, and hepatoma-targeted drug delivery","volume":"3","author":"Chen","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.chembiol.2013.04.007","article-title":"DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology","volume":"20","author":"Cheung-Ong","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejpb.2007.03.022","article-title":"Poly(ethylene oxide)\u2013poly (propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs","volume":"66","author":"Chiappetta","year":"2007","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/nnm.09.90","article-title":"Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability","volume":"5","author":"Chiappetta","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11814-010-0216-5","article-title":"Polymeric nanoparticles, micelles and polymersomes from amphiphilic block copolymer","volume":"27","author":"Cho","year":"2010","journal-title":"Korean J. Chem. Eng."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib36","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1016\/j.biomaterials.2012.05.029","article-title":"Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer","volume":"33","author":"Choi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib37","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1016\/j.bmcl.2012.09.012","article-title":"Downregulation of mdr1 and abcg2 genes is a mechanism of inhibition of efflux pumps mediated by polymeric amphiphiles","volume":"22","author":"Cuestas","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib38","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1021\/acsnano.5b01077","article-title":"A PEGylation-free biomimetic porphyrin nanoplatform for personalized cancer theranostics","volume":"9","author":"Cui","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib39","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/sj.bjc.6601856","article-title":"Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer","volume":"90","author":"Danson","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib40","first-page":"1","article-title":"Pluronic based nano-delivery systems; prospective warrior in war against cancer","volume":"1","author":"Dehghankelishadi","year":"2016","journal-title":"Nanomed. Res. J."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib41","first-page":"356","article-title":"DOX-loaded PEG-PLGA and Pluronic copolymer composite micelles enhances cytotoxicity and the intracellular accumulation of drug in DOX-resistant tumor cells","volume":"65","author":"Diao","year":"2010","journal-title":"Die Pharmazie"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-012-1254-1","article-title":"Applications of polymeric micelles with tumor targeted in chemotherapy","volume":"14","author":"Ding","year":"2012","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib43","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1158\/0008-5472.CAN-08-2747","article-title":"Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP","volume":"69","author":"Dong","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.colsurfb.2013.09.010","article-title":"Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration","volume":"114","author":"Dou","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"5","key":"10.1016\/B978-0-12-813627-0.00008-9_bib45","first-page":"776","article-title":"Nanoparticle formulations of cisplatin for cancer therapy","volume":"8","author":"Duan","year":"2016","journal-title":"Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib46","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/01635581.2016.1187281","article-title":"Intratumoral concentrations and effects of orally administered micellar curcuminoids in glioblastoma patients","volume":"68","author":"D\u00fctzmann","year":"2016","journal-title":"Nutr. Cancer"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib47","first-page":"1","article-title":"Oral absorption, intestinal metabolism and human oral bioavailability","author":"El-Kattan","year":"2012","journal-title":"Top. Drug Metabol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib48","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1039\/C4SC03080J","article-title":"Design of an intelligent sub-50nm nuclear-targeting nanotheranostic system for imaging guided intranuclear radiosensitization","volume":"6","author":"Fan","year":"2015","journal-title":"Chem. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djs629","article-title":"Combining radiotherapy and cancer immunotherapy: a paradigm shift","author":"Formenti","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib50","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1351\/pac200476071321","article-title":"Polymeric micelles for oral drug delivery: why and how","volume":"76","author":"Francis","year":"2004","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib51","series-title":"Fundamentals of Clinical Trials","author":"Friedman","year":"1998"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejpb.2010.06.007","article-title":"Polymeric micelles for oral drug delivery","volume":"76","author":"Gaucher","year":"2010","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib53","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2011.12.012","article-title":"Polymeric micelles drug delivery system in oncology","volume":"159","author":"Gong","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib54","doi-asserted-by":"crossref","first-page":"10688","DOI":"10.1021\/la8016563","article-title":"Self-associative behavior and drug-solubilizing ability of poloxamine (tetronic) block copolymers","volume":"24","author":"Gonzalez-Lopez","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1359-6454(99)00299-2","article-title":"Polymeric biomaterials","volume":"48","author":"Griffith","year":"2000","journal-title":"Acta Mater."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jso.23262","article-title":"Gastric cancer epidemiology and risk factors","volume":"107","author":"Guggenheim","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11912-010-0103-6","article-title":"Oral cancer chemotherapy: the critical interplay between patient education and patient safety","volume":"12","author":"Halfdanarson","year":"2010","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/02652048.2011.629740","article-title":"Sustained release of low molecular weight heparin from PLGA microspheres prepared by a solid-in-oil-in-water emulsion method","volume":"28","author":"He","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.med.59.061506.185523","article-title":"Nanotechnology and cancer","volume":"59","author":"Heath","year":"2008","journal-title":"Ann. Rev. Med."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/nnm.15.152","article-title":"Personalized medicine: the enabling role of nanotechnology","volume":"11","author":"Herrmann","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib62","first-page":"189","article-title":"Commercialization of nanotechnology","volume":"1","author":"Hobson","year":"2009","journal-title":"Wiley Interdisc. Rev.: Nanomed. Nanobiotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib63","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.2147\/IJN.S92722","article-title":"Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer","volume":"11","author":"Huang","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib64","first-page":"330","article-title":"Development of novel polymeric micelle drug carrier systems for brain tumor therapy","volume":"65","author":"Ino","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib65","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.drudis.2006.07.005","article-title":"Exploiting the enhanced permeability and retention effect for tumor targeting","volume":"11","author":"Iyer","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib66","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/mp400311j","article-title":"Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity","volume":"10","author":"Jain","year":"2013","journal-title":"Mol. Pharmaceut."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0939-6411(99)00039-9","article-title":"Polymeric micelles\u2014a new generation of colloidal drug carriers","volume":"48","author":"Jones","year":"1999","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","article-title":"Pluronic\u00ae block copolymers as novel polymer therapeutics for drug and gene delivery","volume":"82","author":"Kabanov","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib69","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0168-3659(93)90172-2","article-title":"Block copolymer micelles as vehicles for drug delivery","volume":"24","author":"Kazunori","year":"1993","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib71","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.nano.2010.05.005","article-title":"Advances in polymeric micelles for drug delivery and tumor targeting","volume":"6","author":"Kedar","year":"2010","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib72","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/JTO.0000000000000692","article-title":"A prospective phase II study of cisplatin and cremophor EL-free paclitaxel (Genexol-PM) in patients with unresectable thymic epithelial tumors","volume":"10","author":"Kim","year":"2015","journal-title":"J. Thor. Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib73","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1158\/1078-0432.CCR-03-0655","article-title":"Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies","volume":"10","author":"Kim","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/mi.7.6.9","article-title":"Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice","volume":"7","author":"Kinders","year":"2007","journal-title":"Mol. Interven."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib75","series-title":"Encyclopedia of Biomaterials and Biomedical Engineering","article-title":"Polylactic-co-glycolic acid (PLGA)","author":"Konstantinos","year":"2008"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib76","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1002\/chem.200204621","article-title":"Pluronic L61 accelerates flip\u2013flop and transbilayer doxorubicin permeation","volume":"9","author":"Krylova","year":"2003","journal-title":"Chem.\u2013Eur. J."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib77","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1039\/b820162p","article-title":"Synthesis of polycaprolactone: a review","volume":"38","author":"Labet","year":"2009","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2004.06.018","article-title":"Poly(N-vinylpyrrolidone)-block-poly (d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation","volume":"99","author":"Le Garrec","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib79","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.addr.2004.01.008","article-title":"Folate-targeted chemotherapy","volume":"56","author":"Leamon","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib80","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/bc0502107","article-title":"Paclitaxel-loaded poly(\u03b3-glutamic acid)-poly (lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells","volume":"17","author":"Liang","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib81","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1023\/A:1023215320026","article-title":"Stability and release performance of a series of pegylated copolymeric micelles","volume":"20","author":"Lin","year":"2003","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1039\/B916705F","article-title":"Synthetic hydrogels for controlled stem cell differentiation","volume":"6","author":"Liu","year":"2010","journal-title":"Soft Matter"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib83","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1166\/jbn.2015.1945","article-title":"Theranostic polymeric micelles for the diagnosis and treatment of hepatocellular carcinoma","volume":"11","author":"Liu","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1","key":"10.1016\/B978-0-12-813627-0.00008-9_bib84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/17425247.2016.1205585","article-title":"Clinical advances of nanocarrier-based cancer therapy and diagnostics","volume":"14","author":"Luque-Michel","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib86","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4236\/ijcm.2014.521175","article-title":"Clinical trial phases","volume":"5","author":"Mahan","year":"2014","journal-title":"Int. J. Clin. Med."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib87","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1155\/2012\/593878","article-title":"Preparation of folate-conjugated pluronic F127\/chitosan core\u2013shell nanoparticles encapsulating doxorubicin for breast cancer treatment","volume":"2012","author":"Manaspon","year":"2012","journal-title":"J. Nanomater."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib89","series-title":"Nanomedicines: Design, Delivery and Detection","article-title":"Anticancer agent-incorporating polymeric micelles: from bench to bedside","author":"Matsumura","year":"2016"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib90","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1349-7006.2009.01103.x","article-title":"Preclinical and clinical studies of anticancer agent-incorporating polymer micelles","volume":"100","author":"Matsumura","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib91","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.addr.2012.11.005","article-title":"Pharmaceutical nanotechnology for oral delivery of anticancer drugs","volume":"65","author":"Mei","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib92","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0014-5793(99)00208-2","article-title":"Interaction of tumor and normal blood cells with ethylene oxide and propylene oxide block copolymers","volume":"446","author":"Melik-Nubarov","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib93","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11095-012-0903-5","article-title":"Drug loading of polymeric micelles","volume":"30","author":"Miller","year":"2013","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib95","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/j.biomaterials.2011.03.005","article-title":"The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles","volume":"32","author":"Mo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib96","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1516282","article-title":"Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma","volume":"374","author":"Moreau","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib97","series-title":"The 7th IEEE International Conference on Nano\/Molecular Medicine and Engineering","first-page":"95","article-title":"IG-001\u2014a non-biologic micellar paclitaxel formulation for the treatment of metastatic breast cancer","author":"Motamed","year":"2013"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib98","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1158\/1538-7445.AM2014-5414","article-title":"IG-001 potential as intraperitoneal therapy for ovarian cancer","volume":"74","author":"Motamed","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib99","first-page":"691","article-title":"Applications of polymer micelles for imaging and drug delivery","volume":"7","author":"Movassaghian","year":"2015","journal-title":"Wiley Interdisc. Rev.: Nanomed. Nanobiotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib100","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s10637-016-0381-4","article-title":"Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors","volume":"34","author":"Mukai","year":"2016","journal-title":"Investig. New Drugs"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib101","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.biomaterials.2014.11.008","article-title":"Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters","volume":"39","author":"Muthu","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib102","series-title":"Tissue Engineering I","article-title":"Polymers as biomaterials for tissue engineering and controlled drug delivery","author":"Nair","year":"2005"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib103","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.progpolymsci.2007.05.017","article-title":"Biodegradable polymers as biomaterials","volume":"32","author":"Nair","year":"2007","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib104","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.reactfunctpolym.2010.08.006","article-title":"Multi-targeting cancer chemotherapy using temperature-responsive drug carrier systems","volume":"71","author":"Nakayama","year":"2011","journal-title":"Reactive Funct. Polym."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/1061186X.2014.936872","article-title":"Polymeric micelles with stimuli-triggering systems for advanced cancer drug targeting","volume":"22","author":"Nakayama","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib106","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1021\/nl061412u","article-title":"Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems","volume":"6","author":"Nasongkla","year":"2006","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/B978-0-12-813627-0.00008-9_bib107","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/cas.12960","article-title":"Development of polymeric micelles for targeting intractable cancers","volume":"107","author":"Nishiyama","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib108","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bjc.6600591","article-title":"Oral cancer treatment: developments in chemotherapy and beyond","volume":"87","author":"O\u2019Neill","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib109","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s11095-010-0233-4","article-title":"Polymeric micelles in anticancer therapy: targeting, imaging and triggered release","volume":"27","author":"Oerlemans","year":"2010","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/mic.0.081448-0","article-title":"Poly-\u03b3-glutamic acid: production, properties and applications","volume":"161","author":"Ogunleye","year":"2015","journal-title":"Microbiology"},{"issue":"3","key":"10.1016\/B978-0-12-813627-0.00008-9_bib111","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4143\/crt.2016.289","article-title":"An open-label, randomized, parallel, phase III trial evaluating the efficacy and safety of polymeric micelle-formulated paclitaxel compared to conventional cremophor EL-based paclitaxel for recurrent or metastatic HER2-negative breast cancer","volume":"49","author":"Park","year":"2016","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib112","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jnci\/94.9.652","article-title":"Adherence to therapy with oral antineoplastic agents","volume":"94","author":"Partridge","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib113","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/adhm.201300225","article-title":"MRI-visual order\u2013disorder micellar nanostructures for smart cancer theranostics","volume":"3","author":"Patra","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib114","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1590\/S0100-40422012000600003","article-title":"Preparation, characterization and biodegradation studies on blends based on PDLLA and PVP","volume":"35","author":"Paula","year":"2012","journal-title":"Qu\u00edm. Nova"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib115","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1126\/science.8134835","article-title":"New challenges in biomaterials","volume":"263","author":"Peppas","year":"1994","journal-title":"Science"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib116","series-title":"Clinical Trials: A Practical Approach","author":"Pocock","year":"2013"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib117","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.actbio.2011.12.020","article-title":"Hot melt poly-\u03b5-caprolactone\/poloxamine implantable matrices for sustained delivery of ciprofloxacin","volume":"8","author":"Puga","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib118","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1148\/radiology.213.3.r99dc20889","article-title":"Benign versus malignant solid breast masses: US differentiation 1","volume":"213","author":"Rahbar","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib119","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0927-7765(99)00063-6","article-title":"Stabilization and activation of Pluronic micelles for tumor-targeted drug delivery","volume":"16","author":"Rapoport","year":"1999","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib121","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1166\/jnn.2015.9713","article-title":"Polymeric micelles as novel carriers for poorly soluble drugs\u2014review","volume":"15","author":"Reddy","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib122","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.actbio.2015.08.046","article-title":"PEO\u2013PPO\u2013PEO micelles as effective rAAV-mediated gene delivery systems to target human mesenchymal stem cells without altering their differentiation potency","volume":"27","author":"Rey-Rico","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib123","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1098\/rsif.2012.0102","article-title":"Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy","volume":"9","author":"Ribeiro","year":"2012","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib124","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.colsurfb.2012.10.055","article-title":"Poloxamine micellar solubilization of \u03b1-tocopherol for topical ocular treatment","volume":"103","author":"Ribeiro","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcomdis.2004.04.003","article-title":"A five-phase model for clinical-outcome research","volume":"37","author":"Robey","year":"2004","journal-title":"J. Commun. Disorders"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib126","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/annonc\/mdt025","article-title":"Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship","volume":"24","author":"Ruddy","year":"2013","journal-title":"Annal. Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib127","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1021\/mp300633f","article-title":"Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma","volume":"11","author":"Sawant","year":"2013","journal-title":"Mol. Pharmaceut."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib128","first-page":"6706","article-title":"American society of clinical oncology statement: a conceptual framework to assess the value of cancer treatment options","volume":"61","author":"Schnipper","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib129","series-title":"Polymers as Biomaterials","author":"Shalaby","year":"2012"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib130","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/nnano.2015.187","article-title":"Biosensors: microcantilevers to lift biomolecules","volume":"10","author":"Shekhawat","year":"2015","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib131","first-page":"1749","article-title":"Self-assembled mPEG-PCL-g-PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro","volume":"7","author":"Shi","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib132","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0960-8524(01)00074-8","article-title":"The production of poly-(\u03b3-glutamic acid) from microorganisms and its various applications","volume":"79","author":"Shih","year":"2001","journal-title":"Bioresour. Technol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib133","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.2147\/IJN.S91008","article-title":"Therapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinoma","volume":"10","author":"Shih","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/B978-0-12-813627-0.00008-9_bib134","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acs.bioconjchem.6b00184","article-title":"Cancer targeted enzymatic theranostic prodrug: precise diagnosis and chemotherapy","volume":"27","author":"Shin","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib135","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1021\/ie5012799","article-title":"Self-reporting micellar polymer nanostructures for optical urea biosensing","volume":"53","author":"Shukla","year":"2014","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib136","series-title":"Advances in Biomembranes and Lipid Self-Assembly","doi-asserted-by":"crossref","DOI":"10.1016\/bs.abl.2016.04.005","article-title":"Chapter six - polymeric micellar structures for biosensor technology","author":"Shukla","year":"2016"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib137","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1039\/c2sm27298a","article-title":"Co-assemblies of micelle-forming diblock copolymers and enzymes on graphite substrate for an improved design of biosensor systems","volume":"9","author":"Sigolaeva","year":"2013","journal-title":"Soft Matter"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib138","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","article-title":"HIV infection, immunodeficiency, viral replication, and the risk of cancer","volume":"20","author":"Silverberg","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib139","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/17425247.2015.960841","article-title":"Polymeric micelles for oral drug administration enabling locoregional and systemic treatments","volume":"12","author":"Sim\u00f5es","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib141","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/01.ju.0000056085.58221.80","article-title":"The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer","volume":"169","author":"Smith","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib142","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcis.2010.10.024","article-title":"Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo","volume":"354","author":"Song","year":"2011","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib143","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.addr.2015.12.022","article-title":"Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them","volume":"103","author":"Sosnik","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib144","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejps.2012.12.006","article-title":"A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics","volume":"48","author":"Steichen","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib145","doi-asserted-by":"crossref","unstructured":"Stewart, B., Wild, C.P., 2016. World cancer report 2014. World.","DOI":"10.12968\/nuwa.2014.10.2.1142051"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib146","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/17135","article-title":"Molecular characterization of mitochondrial apoptosis-inducing factor","volume":"397","author":"Susin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib147","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.tibtech.2011.06.009","article-title":"Molecular aptamers for drug delivery","volume":"29","author":"Tan","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib148","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejps.2011.03.008","article-title":"Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans","volume":"43","author":"Th\u00f6rn","year":"2011","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib149","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2125.2005.02389.x","article-title":"Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract","volume":"60","author":"Th\u00f6rn","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib150","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2012.5265","article-title":"Designing health care for the most common chronic condition\u2014multimorbidity","volume":"307","author":"Tinetti","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib151","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(01)00299-1","article-title":"Structure and design of polymeric surfactant-based drug delivery systems","volume":"73","author":"Torchilin","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","article-title":"Micellar nanocarriers: pharmaceutical perspectives","volume":"24","author":"Torchilin","year":"2007","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib153","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10637-010-9399-1","article-title":"A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction","volume":"29","author":"Valle","year":"2011","journal-title":"Investig. New Drugs"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib175","unstructured":"VanPutte, C., Regan, J., Russo, A., Seeley, R., Stephens, T., Tate, P., 2014. Digestive System; Seeley\u2019s Anatomy & physiology; 10a ed; New York; McGraw-Hill; 859\u201397."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib154","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12668-012-0047-4","article-title":"Nanotechnology-based biosensors and diagnostics: technology push versus industrial\/healthcare requirements","volume":"2","author":"Vashist","year":"2012","journal-title":"Bionanoscience"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib155","doi-asserted-by":"crossref","unstructured":"Vergote, I., Brize, A., Lisyanskaya, A.S., Lichinitser, M., 2015. Randomized phase III study comparing paclical-carboplatin with paclitaxel-carboplatin in patients with recurrent platinum-sensitive epithelial ovarian cancer. In: ASCO Annual Meeting Proceedings, p. 5517.","DOI":"10.1200\/jco.2015.33.15_suppl.5517"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib156","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.2146\/ajhp070037","article-title":"Managing oral chemotherapy: the healthcare practitioner\u2019s role","volume":"64","author":"Viele","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib157","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib158","first-page":"84","article-title":"D-mannose-conjugated polymeric micelles for targeted drug delivery","volume":"32","author":"Wang","year":"2016","journal-title":"Sheng Wu Gong Cheng Xue Bao [Chin. J. Biotechnol.]"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib159","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2013.02.009","article-title":"Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer","volume":"86","author":"Werner","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib160","unstructured":"WHO, 2016. World Health Organization: fact sheet cancer."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib161","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00396-014-3385-7","article-title":"Fluorescent polymeric micelles containing fluorene derivatives for monitoring drug encapsulation and release","volume":"293","author":"Wu","year":"2015","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib162","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/10717544.2012.690005","article-title":"Preparation and evaluation of folate-modified cationic Pluronic micelles for poorly soluble anticancer drug","volume":"19","author":"Xu","year":"2012","journal-title":"Drug Deliv."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib163","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1016\/j.biomaterials.2013.03.006","article-title":"Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer","volume":"34","author":"Xu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib164","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1158\/1538-7445.AM2014-2648","article-title":"Enhanced antitumor effect of anti tissue factor (TF) antibody-conjugated epirubicin-incorporating polymeric micelles in human cancer xenografts with high TF expression","volume":"74","author":"Yamamoto","year":"2014","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/B978-0-12-813627-0.00008-9_bib165","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1039\/C6CS00026F","article-title":"Metal-containing and related polymers for biomedical applications","volume":"45","author":"Yan","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib166","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/marc.201400650","article-title":"Biodegradable micelles capable of mannose-mediated targeted drug delivery to cancer cells","volume":"36","author":"Yin","year":"2015","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib167","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/17425240903436479","article-title":"Polymeric micelles as a new drug carrier system and their required considerations for clinical trials","volume":"7","author":"Yokoyama","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib168","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijbiomac.2016.01.066","article-title":"Thermo-sensitive complex micelles from sodium alginate-graft-poly(N-isopropylacrylamide) for drug release","volume":"86","author":"Yu","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib169","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/mp100289v","article-title":"Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption","volume":"8","author":"Yuan","year":"2010","journal-title":"Mol. Pharmaceut."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib170","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/mp300213g","article-title":"Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models","volume":"9","author":"Yue","year":"2012","journal-title":"Mol. Pharmaceut."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib171","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12274-014-0619-4","article-title":"Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles for enhanced delivery and antitumor efficacy of paclitaxel","volume":"8","author":"Zhang","year":"2015","journal-title":"Nano Res."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib172","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.nano.2011.11.005","article-title":"Paclitaxel-loaded polymeric micelles based on poly(\u025b-caprolactone)-poly(ethylene glycol)-poly(\u025b-caprolactone) triblock copolymers: in vitro and in vivo evaluation","volume":"8","author":"Zhang","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib173","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1016\/j.biomaterials.2010.02.044","article-title":"Bioactive modification of poly (ethylene glycol) hydrogels for tissue engineering","volume":"31","author":"Zhu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813627-0.00008-9_bib174","doi-asserted-by":"crossref","first-page":"20896","DOI":"10.1038\/srep20896","article-title":"Inhibition of growth and metastasis of colon cancer by delivering 5-fluorouracil-loaded Pluronic P85 copolymer micelles","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Design and Development of New Nanocarriers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136270000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136270000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T08:21:32Z","timestamp":1570868492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128136270000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128136270"],"references-count":175,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-813627-0.00008-9","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}